These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4806965)

  • 21. Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.
    Dhalla NS; Saini-Chohan HK; Rodriguez-Leyva D; Elimban V; Dent MR; Tappia PS
    Cardiovasc Res; 2009 Feb; 81(3):429-38. PubMed ID: 18852252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congestive heart failure: role of cross-bridge cycle kinetics.
    de Tombe PP
    Cardiovasc Res; 1998 Dec; 40(3):440-3. PubMed ID: 10070484
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic remodelling of the failing heart: beneficial or detrimental?
    van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
    Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of calcium cycling defects in advanced heart failure toward molecular therapy.
    Hoshijima M; Knöll R; Pashmforoush M; Chien KR
    J Am Coll Cardiol; 2006 Nov; 48(9 Suppl 1):A15-23. PubMed ID: 17084280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
    Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A1 adenosine receptor upregulation accompanies decreasing myocardial adenosine levels in mice with left ventricular dysfunction.
    Funakoshi H; Zacharia LC; Tang Z; Zhang J; Lee LL; Good JC; Herrmann DE; Higuchi Y; Koch WJ; Jackson EK; Chan TO; Feldman AM
    Circulation; 2007 May; 115(17):2307-15. PubMed ID: 17438146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early ultrastructural and biochemical changes in the myopathic hamster heart.
    Nadkarni BB; Hunt B; Heggtveit HA
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():251-61. PubMed ID: 4283439
    [No Abstract]   [Full Text] [Related]  

  • 28. Changes in crossbridge mechanical properties in diabetic rat cardiomyopathy.
    Joseph T; Coirault C; Dubourg O; Lecarpentier Y
    Basic Res Cardiol; 2005 May; 100(3):231-9. PubMed ID: 15645163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From overload to failure: what happens inside the myocyte.
    Harding SE; Davia K; Davies CH; del Monte F; Money-Kyrle AR; Poole-Wilson PA
    Ann Med; 1998 Aug; 30 Suppl 1():14-23. PubMed ID: 9800879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcomeric dysfunction in heart failure.
    Hamdani N; Kooij V; van Dijk S; Merkus D; Paulus WJ; Remedios CD; Duncker DJ; Stienen GJ; van der Velden J
    Cardiovasc Res; 2008 Mar; 77(4):649-58. PubMed ID: 18055579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in protein kinase A and protein kinase C levels in heart failure due to genetic cardiomyopathy.
    Wang J; Liu X; Arneja AS; Dhalla NS
    Can J Cardiol; 1999 Jun; 15(6):683-90. PubMed ID: 10375719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of creatine in heart failure. A loss-win situation?
    Widder JD; Ertl G
    J Mol Cell Cardiol; 2010 Apr; 48(4):574-5. PubMed ID: 20005879
    [No Abstract]   [Full Text] [Related]  

  • 33. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histochemical and electron microscopic studies of norepinephrine-induced myocardial necrosis in rats.
    Ferrans VJ; Hibbs RG; Cipriano PR; Buja LM
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():495-525. PubMed ID: 4681478
    [No Abstract]   [Full Text] [Related]  

  • 35. Congestive heart failure following chronic tachycardia.
    Coleman HN; Taylor RR; Pool PE; Whipple GH; Covell JW; Ross J; Braunwald E
    Am Heart J; 1971 Jun; 81(6):790-8. PubMed ID: 5088355
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure.
    Babick AP; Dhalla NS
    Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the endothelin system in experimental heart failure.
    Gray GA; Sherry L
    Methods Mol Biol; 2002; 206():217-27. PubMed ID: 12152230
    [No Abstract]   [Full Text] [Related]  

  • 38. [Phosphocreatine, ATP, ADP, AMP and inorganic phosphorus content of the rat heart in various experimental conditions].
    Minelli R; Ceriani T
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1499-502. PubMed ID: 5878164
    [No Abstract]   [Full Text] [Related]  

  • 39. The failing human heart.
    Alpert NR; Mulieri LA; Warshaw D
    Cardiovasc Res; 2002 Apr; 54(1):1-10. PubMed ID: 12062354
    [No Abstract]   [Full Text] [Related]  

  • 40. Congestive heart failure: biochemical and physiologic observations.
    Pool PE
    Am J Med Sci; 1969 Nov; 258(5):328-39. PubMed ID: 4311224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.